GOURI 水靈針

GOURI 聚己內酯注射植入劑

GOURI is an injectable implant made with polycaprolactone (PCL), developed by DEXLEVO Inc. of Seoul, Korea. Unlike particle-based PCL products that suspend microspheres in a gel carrier, GOURI is described by the manufacturer as a fully solubilized, liquid PCL formulation. It is supplied as a 1 mL pre-filled syringe and is intended for use by licensed healthcare professionals only.

How It Differs from Hyaluronic Acid Fillers

• GOURI is not a hyaluronic acid filler and is not designed for immediate volume correction.
• It is positioned as a collagen stimulator, so any change in skin firmness or texture is expected to develop gradually rather than right after treatment.
• Because it is liquid, the material spreads within the tissue instead of staying at a single injection point.

成分背景

• Polycaprolactone (PCL) is a biodegradable synthetic polymer that has been used for many years in medical devices such as absorbable sutures and thread-lift threads.
• Collagen stimulators work by triggering the skin’s natural repair response, during which fibroblasts gradually produce new collagen.

This section describes the general background of the ingredient. It is not a claim of guaranteed results for this product. Published clinical data on liquid PCL are still limited, and treatment decisions should be made by a qualified physician.

產品規格

• 品牌： GOURI 水靈針
• 製造商： DEXLEVO Inc., Seoul, Korea
• Main Ingredient: Polycaprolactone (PCL), 21% (210 mg/mL) as stated by the manufacturer
• 形式： Liquid, particle-free solution in a pre-filled syringe
• Contents: 1 × 1 mL syringe
• 產品類型： Injectable implant (medical device)
• 起源： 韓國

施用

• For use only by licensed healthcare professionals trained in injectable treatments.
• Treatment area, injection depth, technique, volume, number of sessions and post-treatment care must follow the official Instructions for Use (IFU) and the treating physician’s judgment.
• Do not self-administer.

預防措施

• Unlike hyaluronic acid fillers, PCL cannot be dissolved with hyaluronidase after injection. Treatment planning should take this into account.
• Common reactions include pain, redness, swelling and bruising at the injection site. If bruising occurs, it may take longer than usual to fade.
• As with any injectable implant, risks include infection, persistent swelling, allergic reaction, lumps or nodules, and vascular complications.
• Seek medical attention right away if there is rapidly increasing swelling, severe pain, skin color change, blanching or vision changes after treatment.
• Do not use if the packaging is damaged, the syringe is cracked or the product is past its expiry date.
• Single use only. Keep out of reach of children.

Not Suitable / Consult a Physician First

• Pregnant or breastfeeding women
• People with infection, inflammation or skin disease at the treatment area
• People with bleeding disorders or taking medicines that affect blood clotting
• People with known allergy to any component
• People with autoimmune disease, a history of keloids, or other significant medical conditions
• People under 18 years of age

貯存

Store at room temperature, protected from direct sunlight. Do not freeze. Follow the IFU for detailed storage conditions.

重要通知

For professional healthcare use only. This information is for general product reference. It does not replace medical advice, the official Instructions for Use or local regulations. This product is not intended to diagnose, treat, cure or prevent any disease. Results vary between individuals.